SEI Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

SEI Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-104,598	Closed	-$2.24M	–	3314
2026 Q1	$2.24M	Buy	104,598 +67,084	+179%	+$945K	﹤0.01%	1950
2025 Q4	$350K	Buy	+37,514	New	+$313K	﹤0.01%	2668
2023 Q2	–	Sell	-17,342	Closed	-$232K	–	2691
2023 Q1	$232K	Buy	+17,342	New	+$339K	﹤0.01%	2432

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEI Investments's DAWN Position: Q2 2026 in Review

SEI Investments sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 104,598 shares — an estimated $2.24M sold.

SEI Investments first reported a position in DAWN in Q1 2023 and held it in 3 quarters. The position peaked at $2.24M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

SEI Investments reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
SEI Investments sold 104,598 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.24M.
SEI Investments first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 3 quarters.
SEI Investments's Day One Biopharmaceuticals position peaked at $2.24M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.